Both in Biotechnology

Cardiff Oncology vs Cognition Therapeutics

Over the past year CRDF returned −43.8% and CGTX returned −33.3%; their daily moves had a correlation of 0.21.

CRDF −43.8% CGTX −33.3%Growth of $1, one year, split-adjusted
MetricCRDFCGTX
Price$1.17$0.9544
Market cap$91.0M$90.8M
Today−2.50%+1.71%
1 month+24.5%−6.4%
6 months−24.5%+60.5%
Year to date−58.4%−29.3%
1 year−43.2%−28.2%
Revenue growth (YoY)−14.0%—
Gross margin100.0%—
Net margin−8882.7%—
P/E (TTM)——
Price / sales179.2×—
Net cash$34.5M$34.0M
Dividend yield——
Volatility (60d)103.0%50.8%
Short % of float18.0%9.8%
Next earnings——

Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).

CRDF vs CGTX: Cardiff Oncology vs Cognition Therapeutics Stock Comparison | Gainbot